Tacurion Pharma's Unattributed VC Round

Tacurion Pharma raised a round of funding on May 07, 2013.

Tacurion Pharma is a drug development firm lead by Drais Pharmaceuticals. Tacurion is developing ASP7035, a novel, small molecule, selective vasopressin 2 receptor agonist that will be evaluated in a …

Articles about Tacurion Pharma's Unattributed VC Round: